Teledyne CARIS

Teledyne CARIS Announces New Partnership with Seabed 2030 and the UK Hydrographic Office

Retrieved on: 
Tuesday, June 22, 2021

For over 40 years, Teledyne CARIS has been the leader in the development of hydrographic and marine geospatial software.

Key Points: 
  • For over 40 years, Teledyne CARIS has been the leader in the development of hydrographic and marine geospatial software.
  • One of Teledyne CARIS newest products CARIS Onboard360 is a near real-time and autonomous data acquisition and processing package.
  • Seabed 2030 is delighted to announce this new partnership with UKHO and Teledyne CARIS on the occasion of World Hydrography Day.
  • We are extremely excited to enter this new partnership with Teledyne CARIS and The Nippon Foundation-GEBCO Seabed 2030 Project, said Peter Sparkes, Chief Executive at the UK Hydrographic Office.

Teledyne Optech launches CZMIL SuperNova, a full geospatial bathymetric lidar solution with industry-leading depth penetration

Retrieved on: 
Tuesday, June 15, 2021

VAUGHAN, Ontario, June 15, 2021 (GLOBE NEWSWIRE) -- Teledyne Optech and Teledyne CARIS, both Teledyne Technologies [NYSE:TDY] companies and global leaders in advanced lidar sensors and marine mapping software, announce their next generation bathymetric lidar, the CZMIL SuperNova.

Key Points: 
  • VAUGHAN, Ontario, June 15, 2021 (GLOBE NEWSWIRE) -- Teledyne Optech and Teledyne CARIS, both Teledyne Technologies [NYSE:TDY] companies and global leaders in advanced lidar sensors and marine mapping software, announce their next generation bathymetric lidar, the CZMIL SuperNova.
  • The CZMIL SuperNova boasts the best depth performance and the highest green laser point density in its class.
  • To complete the solution, Teledyne CARIS has integrated its BASE Editor software for seamless data processing capacity.
  • Teledyne Optech is a part of the Teledyne Imaging Group and a world leader in high-accuracy lidar 3D survey systems, integrated cameras, and productivity-enhancing workflows.

New Research from Caris Life Sciences Finds Immunotherapy Resistance in Leiomyosarcoma

Retrieved on: 
Friday, June 4, 2021

Caris Life Sciencesis a leading innovator in molecular scienceand artificial intelligencefocused on fulfilling the promise of precision medicine through quality and innovation.

Key Points: 
  • Caris Life Sciencesis a leading innovator in molecular scienceand artificial intelligencefocused on fulfilling the promise of precision medicine through quality and innovation.
  • With over 420 research sites within the Caris Pharmatech Just-In-Time (JIT) Oncology Network, biopharma companies can identify and enroll more patients, faster.
  • Headquartered in Irving, Texas, Caris Life Sciences has offices in Phoenix, Denver, New York, and Basel, Switzerland.
  • Caris Life Sciences Media & Company Contact:

Caris Life Sciences Announces Appointment of Joseph E. Gilliam to Board of Directors

Retrieved on: 
Wednesday, April 28, 2021

b'IRVING, Texas, April 28, 2021 /PRNewswire/ --Caris Life Sciences, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the appointment of Joseph E. Gilliam to the Caris Board of Directors, effective April 12, 2021.

Key Points: 
  • b'IRVING, Texas, April 28, 2021 /PRNewswire/ --Caris Life Sciences, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced the appointment of Joseph E. Gilliam to the Caris Board of Directors, effective April 12, 2021.
  • Following the appointment of Mr. Gilliam, the Board will be comprised of 10 directors.\nThe Caris Life Sciences Board of Directors is responsible for the overall management of the company, including guiding strategies and monitoring company performance.
  • Many of the current directors have held leadership roles at major domestic and international companies, academic and scientific organizations, and governmental agencies.\n"We are pleased to welcome Joe to the Caris Board," said David D. Halbert , Chairman and CEO of Caris Life Sciences.
  • "\n"I am excited to join the Caris Board, and look forward to working alongside fellow board members and Caris\' management team," said Mr. Gilliam.

TestEquity Appoints New Executive Leadership

Retrieved on: 
Wednesday, April 7, 2021

Derrick joins TestEquity from Caris Life Sciences, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine.

Key Points: 
  • Derrick joins TestEquity from Caris Life Sciences, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine.
  • Additionally, he has more than 20 years of executive leadership experience in the technology and distribution space.
  • Derricks rich and varied experiences as a seasoned professional in sales operations, makes him a valuable addition to the team at TestEquity, said Steve Newland, Chief Executive Officer of TestEquity.
  • TestEquity is perfectly positioned to help its customers expand their business and improve the overall customer experience which allows us to compete in the modern distribution marketplace, stated Derrick Jones, SVP of Sales, TestEquity.

Pascale Foundation, Member of Italy's Institute of Hospitalization and Treatment, Joins Caris Life Sciences' Precision Oncology Alliance

Retrieved on: 
Tuesday, April 6, 2021

The institute pursues clinical research and applied research in the biomedical field, along with the organization and management of health services.

Key Points: 
  • The institute pursues clinical research and applied research in the biomedical field, along with the organization and management of health services.
  • "We are excited to welcome the Pascale Foundation into the POA," said Chadi Nabhan , M.D., MBA, FACP,Chairman of the Caris Precision Oncology Alliance.
  • The Caris Precision Oncology Alliance includes 49 cancer centers and academic institutions.
  • Caris Life Sciences is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation.

Teledyne CARIS announces its complete workflow software, Onboard360, featuring data acquisition with CARIS Collect

Retrieved on: 
Tuesday, March 16, 2021

FREDERICTON, New Brunswick, March 16, 2021 (GLOBE NEWSWIRE) -- Teledyne CARIS , a Teledyne Technologies [NYSE:TDY] company, and leading developer of marine mapping software, is pleased to announce the release of Onboard360 featuring CARIS Collect.

Key Points: 
  • FREDERICTON, New Brunswick, March 16, 2021 (GLOBE NEWSWIRE) -- Teledyne CARIS , a Teledyne Technologies [NYSE:TDY] company, and leading developer of marine mapping software, is pleased to announce the release of Onboard360 featuring CARIS Collect.
  • The CARIS Collect module provides simple and effective data collection for the most common sonar and lidar systems in the market.
  • Available as a perpetual or SaaS annual license, Teledyne CARIS has made Onboard360 the most cost-effective acquisition software package on the market.
  • Teledyne CARIS is hosting a webinar on Thursday, March 25, 2021 at 10:00 a.m. EDT to expand on key features and benefits of Onboard360 and the CARIS Collect module.

Caris Life Sciences to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference 2021

Retrieved on: 
Tuesday, February 9, 2021

Caris Life Sciences is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation.

Key Points: 
  • Caris Life Sciences is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation.
  • With over 350 research sites within the Caris Pharmatech Just-In-Time (JIT) Oncology Network, biopharma companies can identify and enroll more patients, faster.
  • Caris Pharmatech Just-In-Time Clinical Trial Solutions focus on rapid site activation and patient enrollment to streamline the drug development process.
  • Headquartered in Irving, Texas, Caris Life Sciences has offices in Phoenix, Denver, New York, and Basel, Switzerland.

Teledyne CARIS receives Canada’s Ocean Supercluster award through the Accelerated Ocean Solutions Program

Retrieved on: 
Wednesday, November 25, 2020

FREDERICTON, N.B., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teledyne CARIS , a Teledyne Technologies [NYSE:TDY] company, is pleased to announce significant funding from Canadas Ocean Supercluster award to develop software for remote operations survey processing.

Key Points: 
  • FREDERICTON, N.B., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Teledyne CARIS , a Teledyne Technologies [NYSE:TDY] company, is pleased to announce significant funding from Canadas Ocean Supercluster award to develop software for remote operations survey processing.
  • Teledyne CARIS project aims at three targeted deliverables:
    Infusing its passion for future ocean mappers with access to virtual training through the CARIS Cloud Platform.
  • Collaborating with Canadas Ocean Supercluster is something we have been keen to do and through the Accelerated Ocean Solutions Program we have found our platform.
  • See the full CARIS Cloud Project award announcement from Canadas Ocean Supercluster here: https://youtu.be/NKXDV1H2LIg
    Teledyne CARIS is part of the Teledyne Imaging group.

Caris Life Sciences Launches CODEai - Real-World Clinico-Genomic Data Platform Powered by Artificial Intelligence

Retrieved on: 
Tuesday, October 13, 2020

"Combining high-quality, comprehensive molecular and outcomes data within big data architecture, allows CODEai users to effortlessly manipulate thousands of inputs to see the relationship between molecular signatures and responses to truly decode cancer," said Jim Abraham , Ph.D., Chief Data Officer and SVP, Cognitive Computing of Caris Life Sciences.

Key Points: 
  • "Combining high-quality, comprehensive molecular and outcomes data within big data architecture, allows CODEai users to effortlessly manipulate thousands of inputs to see the relationship between molecular signatures and responses to truly decode cancer," said Jim Abraham , Ph.D., Chief Data Officer and SVP, Cognitive Computing of Caris Life Sciences.
  • Caris Life Sciences is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation.
  • Caris is also advancing precision medicine with Caris MAI (Molecular Artificial Intelligence) that combines its innovative service offerings, Caris Molecular Intelligence with its proprietary artificial intelligence analytics engine, DEAN, to analyze the whole exome, whole transcriptome and complete cancer proteome.
  • Headquartered in Irving, Texas, Caris Life Sciences has offices in Phoenix, Denver, New York, and Basel, Switzerland.